Albireo pharma, inc. announces presentations at naspghan 2019 annual meeting

Albireo pharma, inc. announced upcoming presentations at the north american society for pediatric gastroenterology, hepatology and nutrition (naspghan) 2019 annual meeting, being held october 16-19, 2019, in chicago. the presentations will include pharmacological data regarding the company’s lead product candidate, odevixibat, as well as background about the company’s proprietary patient- and observer-reported outcomes assessment tools for pruritus.
ALBO Ratings Summary
ALBO Quant Ranking